Table 2.
Steroid doses anthropometric values and disease activity markers at baseline and one year (population: ITT).
| Variable | Visit | Mean (SD) |
||
|---|---|---|---|---|
| Placebo | Alfacalcidol | Risedronate | ||
| Daily Prednisolonea Mean ± SD |
Baseline | 76 12.20 (8.83) |
70 13.83 (10.97) |
69 16.91 (22.69) |
| One year | 65 5.88 (6.40) |
59 5.82 (4.83) |
55 6.17 (5.44) |
|
| Height cms | Baseline | 145.0 (18.6) | 145.3 (21.3) | 144.6 (19.9) |
| One year | 149.0 (15.5) | 149.9 (20.2) | 148.7 (19.2) | |
| Weight Kg | Baseline | 46.14 (17.41) | 48.24 (20.79) | 48.05 (18.87 |
| One year | 49.82 (17.85) | 53.62 (23.08) | 51.56 (18.79) | |
| Hb g/dl | Baseline | 12.8 (1.36) | 12.6 (1.31) | 12.5 (1.25) |
| One year | 12.6 (1.53) | 12.5 (1.14) | 12.5 (1.12) | |
| ESR mm/h | Baseline | 14.7 (17.1) | 16.2 (13.6) | 14.7 (16.7) |
| One year | 11.0 (11.7) | 15.9 (17.8) | 16.0 (21.5) | |
| CRP mg/L | Baseline | 5.2 (5.8) | 7.8 (11.4) | 7.8 (9.5) |
| One year | 4.8 (5.2) | 6.2 (6.2) | the5.7 (5.7) | |
| ALP IU/L | Baseline | 187.0 (126.6) | 196.1 (133.2) | 179.1 (112.4) |
| One year | 217.8 (158.5) | 233.4 (191.9) | 214.9 (155.8) | |
One in placebo, 4 in alfacalcidol and 4 in risedronate groups. For these, the daily prednisolone equivalent was calculated.
a
Two patients were treated with deflazacort, and one hydrocortisone. Nine patients received methylprednisolone pulses.